Why the CEO Sells 31,000 Shares Worth of AXT Stock
When a company's CEO sells 31,000 shares worth roughly $1.41 million, it sparks questions for investors. This guide e...
What To Avoid When Redeeming Credit Card Points
Redeeming credit card points can be tricky. Discover what to avoid to ensure you make the most out of your rewards and benefits.
19,422 articles
A $2,000 Monthly Pension Makes Your Portfolio Work
A growing share of Americans rely on pensions to anchor retirement. This piece breaks down how a $2,000 monthly pensi...
Stock Market Today, March: Snap Slump After EU Probe
Tech shares wobble as regulatory headlines hit the tape. This piece breaks down the Snap slump, regulatory risks from...
Should You Rely Your Taxes? Experts Warn of AI Risks
As AI tax prep tools surge this season, experts warn that convenience can come with risky gaps. taxpayers weigh speed...
Dave Ramsey Says $165,000 Is Not a Financial Problem
A high-earning couple weighs a public-service run with a $34,000 pay cut, but Ramsey-trained finance logic says the r...
Oklo Stock Racing Higher as Aurora Reactor Cleared
Investors are buzzing about Oklo as the Aurora Powerhouse regulatory path becomes clearer. This piece breaks down wha...
Why Nice Stock Plummeted Today: What Investors Should Do
Nice stock plummeted today after a mixed earnings release, signaling a need to look beyond a single headline. This gu...
Blue Fever Plagues Musicians as Tours See Cancellations Mount
Major acts are trimming or canceling large legs of US tours as fans face higher prices and travel costs. Industry wat...
Apyx Medical (APYX) 2026 Earnings Outlook and Strategy
Apyx Medical (APYX) 2026 is shaping up as a pivotal year for investors. This guide breaks down how to read the Q1 tra...
Ripple (XRP) vs Solana (SOL): Smarter Buy This Summer
Crypto traders are weighing ripple (xrp) solana (sol) as summer enters. The rivals push higher, but investors cite di...
Pfizer Lilly: Different Bets on Pharma M&A Explained
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status